Trademark: 90322039
Word
MOTIVY
Status
Dead
Status Code
606
Status Date
Monday, January 15, 2024
Serial Number
90322039
Mark Type
4000
Filing Date
Monday, November 16, 2020
Published for Opposition
Tuesday, April 19, 2022
Abandoned Date
Monday, January 15, 2024

Trademark Owner History
GW Research Limited - Owner At Publication

Classifications
5 Pharmaceutical preparations and substances for the treatment of neurological conditions, disorders and diseases; pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorders, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders and drug, alcohol and nicotine abuse; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorders, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders and drug, alcohol and nicotine abuse; pure extracts of medicinal plants for medical purposes; plant extracts for pharmaceutical purposes

Trademark Events
Jan 16, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 15, 2024
Abandonment - No Use Statement Filed
May 24, 2023
Notice Of Approval Of Extension Request E-Mailed
May 22, 2023
Sou Extension 2 Granted
May 22, 2023
Sou Extension 2 Filed
May 22, 2023
Sou Teas Extension Received
Nov 22, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 20, 2022
Sou Extension 1 Granted
Nov 20, 2022
Sou Extension 1 Filed
Nov 20, 2022
Sou Teas Extension Received
Jun 14, 2022
Noa E-Mailed - Sou Required From Applicant
Apr 19, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 19, 2022
Published For Opposition
Mar 30, 2022
Notification Of Notice Of Publication E-Mailed
Mar 13, 2022
Approved For Pub - Principal Register
Feb 12, 2022
Teas/Email Correspondence Entered
Feb 11, 2022
Correspondence Received In Law Office
Feb 11, 2022
Teas Response To Suspension Inquiry Received
Sep 19, 2021
Notification Of Letter Of Suspension E-Mailed
Sep 19, 2021
Letter Of Suspension E-Mailed
Sep 19, 2021
Suspension Letter Written
Sep 15, 2021
Teas Change Of Correspondence Received
Sep 15, 2021
Teas Change Of Domestic Representatives Address
Sep 15, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 15, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 20, 2021
Teas/Email Correspondence Entered
Aug 20, 2021
Correspondence Received In Law Office
Aug 20, 2021
Teas Response To Office Action Received
May 3, 2021
Notification Of Non-Final Action E-Mailed
May 3, 2021
Non-Final Action E-Mailed
May 3, 2021
Non-Final Action Written
Apr 26, 2021
Assigned To Examiner
Jan 15, 2021
New Application Office Supplied Data Entered
Nov 19, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24